These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 19771430

  • 1. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J, Melguizo C, Rama AR, Ortiz R, Segura A, Boulaiz H, Vélez C, Caba O, Ramos JL, Aránega A.
    Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
    [Abstract] [Full Text] [Related]

  • 2. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.
    Rama AR, Prados J, Melguizo C, Burgos M, Alvarez PJ, Rodriguez-Serrano F, Ramos JL, Aranega A.
    Biomed Pharmacother; 2011 Jul; 65(4):260-70. PubMed ID: 21723082
    [Abstract] [Full Text] [Related]

  • 3. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells.
    Prados J, Melguizo C, Rama A, Ortiz R, Boulaiz H, Rodriguez-Serrano F, Caba O, Rodriguez-Herva JJ, Ramos JL, Aranega A.
    Int J Oncol; 2008 Jul; 33(1):121-7. PubMed ID: 18575757
    [Abstract] [Full Text] [Related]

  • 4. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells.
    Ortiz R, Prados J, Melguizo C, Rama AR, Alvarez PJ, Rodríguez-Serrano F, Caba O, Boulaiz H, Aranega A.
    Biomed Pharmacother; 2012 Oct; 66(7):563-7. PubMed ID: 22770988
    [Abstract] [Full Text] [Related]

  • 5. Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids.
    Oktem G, Vatansever S, Ayla S, Uysal A, Aktas S, Karabulut B, Bilir A.
    Oncol Rep; 2006 Feb; 15(2):335-40. PubMed ID: 16391851
    [Abstract] [Full Text] [Related]

  • 6. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H, Taira N, Nogami T, Shien K, Okada M, Shien T, Doihara H, Miyoshi S.
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [Abstract] [Full Text] [Related]

  • 7. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z, Goulet R, Stanton KJ, Sadaria M, Nakshatri H.
    Anticancer Res; 2005 Nov; 25(3c):2367-79. PubMed ID: 16080463
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA, Di X, Walker TD, Sawyer ST.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [Abstract] [Full Text] [Related]

  • 9. A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin.
    Boulaiz H, Aránega A, Cáceres B, Alvarez P, Serrano-Rodríguez F, Carrillo E, Melguizo C, Prados J.
    BioDrugs; 2014 Feb 01; 28(1):63-74. PubMed ID: 23921576
    [Abstract] [Full Text] [Related]

  • 10. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV, Wu Y, Shen D, Hsia S, Block J.
    Anticancer Res; 2000 Feb 01; 20(3A):1391-414. PubMed ID: 10928049
    [Abstract] [Full Text] [Related]

  • 11. Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.
    Trebunova M, Laputkova G, Slaba E, Lacjakova K, Verebova A.
    Anticancer Res; 2012 Jul 01; 32(7):2849-54. PubMed ID: 22753747
    [Abstract] [Full Text] [Related]

  • 12. Modulation of Ki-67 expression and morphological changes induced by gef gene in MCF-7 human breast cancer cells.
    Boulaiz H, Prados J, Marchal JA, Melguizo C, Concha A, Carrillo E, Vélez C, Martínez A, Aránega A.
    Cell Mol Biol (Noisy-le-grand); 2005 Sep 02; 51(1):87-92. PubMed ID: 16171567
    [Abstract] [Full Text] [Related]

  • 13. In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells.
    Zeng S, Chen YZ, Fu L, Johnson KR, Fan W.
    Clin Cancer Res; 2000 Sep 02; 6(9):3766-73. PubMed ID: 10999771
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ.
    Chin Med J (Engl); 2008 Oct 20; 121(20):1975-9. PubMed ID: 19080259
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7.
    Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R.
    J BUON; 2009 Oct 20; 14(3):479-85. PubMed ID: 19810142
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D.
    Oncogene; 1999 Apr 01; 18(13):2241-51. PubMed ID: 10327070
    [Abstract] [Full Text] [Related]

  • 17. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
    Greco O, Powell TM, Marples B, Joiner MC, Scott SD.
    Cancer Gene Ther; 2005 Jul 01; 12(7):655-62. PubMed ID: 15818381
    [Abstract] [Full Text] [Related]

  • 18. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
    Sakin V, Eskiocak U, Kars MD, Iseri OD, Gunduz U.
    Exp Oncol; 2008 Sep 01; 30(3):202-5. PubMed ID: 18806742
    [Abstract] [Full Text] [Related]

  • 19. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F, Duivenvoorden WC, Singh G.
    Anticancer Drugs; 2009 Feb 01; 20(2):115-22. PubMed ID: 19209028
    [Abstract] [Full Text] [Related]

  • 20. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ.
    Oncogene; 1998 Oct 29; 17(17):2235-49. PubMed ID: 9811454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.